Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1608: CTC categorization: Subpopulations of CTCs and their potential clinical significance

View through CrossRef
Abstract Circulating tumor cells (CTCs) were previously rare events difficult to identify. In clinical practice, CTC enumeration has now been recognized for its prognostic value. Furthermore, as CTC technology has rapidly improved, CTCs are now readily available for further investigation. The tumor cells isolated from CTC instruments may be analyzed for molecular profiles and mutation screening. Here we propose three new subsets of CTCs: elongated CTC (EL-CTC), miniature CTC (Mini-CTC) and cluster CTC (CL-CTC). Elongated CTC have an elongated shape and some of these cells have an enlarged tail composed of the nucleus. The enlarged tail is formed during intravasation because of the less flexible nuclear membrane and these cells represent highly motile tumor cells. The mini-CTCs are much smaller than regular tumor cells and may be dormant and gain the advantage of escaping immune surveillance. The CTC clusters are formed by a group of tumor cells and lymphocytes as well as macrophages. There is strong evidence that these clusters are highly malignant. These three subsets are recognized morphologically and their unique features may directly relate to their functionality and clinical significance. Additional investigation in the area of CTC research, specifically enhanced understanding of CTC subpopulations, may lead to novel therapeutic approaches in oncology. Citation Format: Chengsen Xue, Thomas W. Mc Closkey. CTC categorization: Subpopulations of CTCs and their potential clinical significance. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1608. doi:10.1158/1538-7445.AM2015-1608
American Association for Cancer Research (AACR)
Title: Abstract 1608: CTC categorization: Subpopulations of CTCs and their potential clinical significance
Description:
Abstract Circulating tumor cells (CTCs) were previously rare events difficult to identify.
In clinical practice, CTC enumeration has now been recognized for its prognostic value.
Furthermore, as CTC technology has rapidly improved, CTCs are now readily available for further investigation.
The tumor cells isolated from CTC instruments may be analyzed for molecular profiles and mutation screening.
Here we propose three new subsets of CTCs: elongated CTC (EL-CTC), miniature CTC (Mini-CTC) and cluster CTC (CL-CTC).
Elongated CTC have an elongated shape and some of these cells have an enlarged tail composed of the nucleus.
The enlarged tail is formed during intravasation because of the less flexible nuclear membrane and these cells represent highly motile tumor cells.
The mini-CTCs are much smaller than regular tumor cells and may be dormant and gain the advantage of escaping immune surveillance.
The CTC clusters are formed by a group of tumor cells and lymphocytes as well as macrophages.
There is strong evidence that these clusters are highly malignant.
These three subsets are recognized morphologically and their unique features may directly relate to their functionality and clinical significance.
Additional investigation in the area of CTC research, specifically enhanced understanding of CTC subpopulations, may lead to novel therapeutic approaches in oncology.
Citation Format: Chengsen Xue, Thomas W.
Mc Closkey.
CTC categorization: Subpopulations of CTCs and their potential clinical significance.
[abstract].
In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA.
Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1608.
doi:10.
1158/1538-7445.
AM2015-1608.

Related Results

Abstract P2-10-26: Association between circulating tumor cells and molecular breast cancer subtypes
Abstract P2-10-26: Association between circulating tumor cells and molecular breast cancer subtypes
Abstract Background and Objective: Circulating tumor cells (CTCs) provide crucial information for the management of breast cancer patients. CTCs analysis can be used...
Abstract 796: Molecular characterization of circulating tumor cells using fluidigm biomark dynamic array
Abstract 796: Molecular characterization of circulating tumor cells using fluidigm biomark dynamic array
Abstract Circulating tumor cells (CTCs) are cancer cells derived from a primary tumor and/or its metastases that circulate in the peripheral blood. The number of CTC...
Abstract 1532: The isolation of CTC from diagnostic leukapheresis
Abstract 1532: The isolation of CTC from diagnostic leukapheresis
Abstract Introduction At present, the CellSearch system is the only validated method for the detection of circulating tumor cells (CTC) that has been ...
Revolutionizing PDAC Treatment: Exploring the Potential of CTC Detection
Revolutionizing PDAC Treatment: Exploring the Potential of CTC Detection
Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent kind of pancreatic cancer, which is highly aggressive and responds poorly to traditional therapy. Circulating tumor ce...
Liquid Biopsy in Early Breast Cancer: A Preliminary Report
Liquid Biopsy in Early Breast Cancer: A Preliminary Report
Background: Liquid biopsy (LB) is a technique that utilizes circulating biomarkers from cancer patients to provide information regarding the genetic landscape of the cancer. LB is ...
GeTMoR: Simultaneous genomic, transcriptomic, and morphological profiling of rare single cells
GeTMoR: Simultaneous genomic, transcriptomic, and morphological profiling of rare single cells
1AbstractCirculating tumor cells (CTCs), and circulating tumor related cells, are extremely rare cells that intravasate from the tumor into the circulatory system and can be captur...
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
AbstractBackgroundRadical surgery is the first line treatment for localized prostate cancer (PC), however, several studies have demonstrated that surgical procedures induce tumor c...

Back to Top